PXMD

PaxMedica Inc

1.36
0.0701 (5.43%)

PaxMedica Inc. (PXMD) Fundamentals

PaxMedica Inc an early clinical stage biopharmaceutical company focusing on the development of anti-purinergic therapies (or APT), for the treatment of neurodevelopmental disorders, including autism spectrum disorder (or ASD), and Fragile X syndrome tremor-ataxia (or FXTAS). It focuses on the development and testing of its lead program, PAX-101, an intravenous formulation of suramin, in the treatment of ASD and FXTAS. It is also focused on the treatment of Human African Trypanosomiasis (or HAT). Its candidate PAX-102, proprietary intranasal formulation of suramin, as well as other new chemical entities that are more targeted and highly selective antagonists of particular purinergic receptor subtypes.
SHARE INFORMATION
Market Cap$ 18,857,663
Shares Outstanding14,619,477
Float5,737,170
Percent Float39.24%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ 0.00
Latest Fiscal Date2023-03-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions21
Institutional Holdings Date2023-03-31
Institutional Bought Previous 3 Months67,342
Institutional Holdings Percent1.4%
Institutional Sold Previous 3 Months3,985
Insider Holdings Date2023-03-31
Insider Bought Previous 3 Months-
Insider Holdings Percent1.9
Insider Sold Previous 3 Months269,463
Insider Shares Owned1,264,165
TRADING INFO
52 Week High$ 10.48
52 Week Low$ 1.26
52 Week High Change$ 0.00
21 Day Moving Average$ 1.4883
21 Day Extended Moving Average$ 1.4881
50 Day Moving Average$ 1.6893
50 Day Extended Moving Average$ 1.6681
200 Day Moving Average$ 2.2396
200 Day Extended Moving Average$ 2.4526
10 Day Average Volume164,022
20 Day Average Volume232,956
30 Day Average Volume304,730
50 Day Average Volume525,528
Alpha-0.084071
Beta1.8420
Standard Deviation0.185618
R20.330899
7 Day Price Change$ -0.1501
7 Day Percent Change-10.42%
21 Day Price Change$ -0.2601
21 Day Percent Change-16.78%
30 Day Price Change$ -0.1801
30 Day Percent Change-12.25%
Month to Date Price Change$ -0.0501
Month to Date Percent Change-3.74%
Quarter to Date Price Change$ -0.6201
Quarter to Date Percent Change-32.47%
180 Day Price Change$ -1.41
180 Day Percent Change-52.23%
200 Day Price Change$ -0.1601
200 Day Percent Change-11.04%
Year to Date Price Change$ -0.7401
Year to Date Percent Change-36.46%

PaxMedica Inc. (PXMD) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book184.10
Total Debt To Equity1.60
Int Coverage0.00
Current Ratio1.10
Leverage Ratio20.30
Quick Ratio0.90
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio0.00
Enterprise Value$ 0
Price to Sales0.00
Price to Free Cash0.00
PE High Last 5 Years0.00
Price To Book184.10
Price To Cash Flow-1.60
PE Low Last 5 Years-0.50
Price to Tangible Book184.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-1,037.56
Return on Equity0.00
Return on Capital301.16

PaxMedica Inc. (PXMD) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
Auditor-
CEOHoward J. Weisman
Employees-
Last Audit-
CIK0001811623
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address50 Tice Boulevard,Suite A26
Suite 125
Woodcliff Lake, NJ 7677
Websitehttps://www.paxmedica.com
Facsimile-
Telephone+1 201 645-4765
Emailinfo@paxmedica.com


Your Recent History
NASDAQ
PXMD
PaxMedica
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.